Markets:

Overview

News

Currencies

International

Treasuries

AbbVie (NY:ABBV)

234.76 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

2 Value Stocks Worth Your Attention and 1 Facing Headwinds

Today 0:31 EDT

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether t...

Via StockStory

3 Monster Stocks to Hold for the Next 10 Years ↗

June 23, 2026

These healthcare stocks may be the building blocks of a winning portfolio.

Via The Motley Fool

Topics Intellectual Property

Why AbbVie Stock Jumped Today ↗

June 22, 2026

An intriguing acquisition could bring exciting new drugs into the medicine maker's development pipeline.

Via The Motley Fool

AbbVie's $10.9 Billion Apogee Deal Will Extend Its Immunology Dominance: Is It Time to Load Up on This Dividend King? ↗

June 22, 2026

The company is already renowned by many as a giant in the segment.

Via The Motley Fool

AbbVie Inc (NYSE:ABBV) Breakout Setup Combines Strong Technical Rating with High-Quality Consolidation Entry ↗

June 17, 2026

Via Chartmill

Monday's session: top gainers and losers in the S&P500 index ↗

June 22, 2026

Via Chartmill

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Apogee Therapeutics, Inc. (Nasdaq – APGE), Simulations Plus, Inc. (Nasdaq – SLP), Roku, Inc. (Nasdaq – ROKU), TruBridge, Inc. (Nasdaq – TBRG)

June 22, 2026

From Brodsky & Smith LLC

Via GlobeNewswire

Explore the top gainers and losers within the S&P500 index in today's session. ↗

June 22, 2026

Via Chartmill

5 Dividend Stocks to Buy and Hold Forever ↗

June 22, 2026

Get rich slowly. How? Hold these stocks and reinvest the dividends they pay.

Via The Motley Fool

Topics Intellectual Property

3 Excellent Dividend Stocks to Buy on the Dip ↗

June 22, 2026

Don't wait too long to get in on these outstanding dividend payers.

Via The Motley Fool

Topics Artificial Intelligence Economy Intellectual Property

2 Profitable Stocks Worth Your Attention and 1 We Avoid

June 22, 2026

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifi...

Via StockStory

How Many Botox Units Do You Need: Forehead, Crow's Feet, and Frown Lines

June 18, 2026

Via Press Release Distribution Service

3 High-Yield Dividend Stocks to Buy Hand Over Fist in June ↗

June 15, 2026

Now's the time to load up on these high-yielders.

Via The Motley Fool

Topics Economy

June 12, 2026

Driving revenue growth and earnings growth are two different things.

Via The Motley Fool

Topics Intellectual Property

AbbVie Reports Promising New Clinical Updates. Here's What It Means for the Company's Dividend. ↗

June 12, 2026

New cancer therapies may help fund dividend growth.

Via The Motley Fool

Topics Intellectual Property

Is AbbVie the Most Underrated Dividend Growth Stock in the S&P 500? ↗

June 08, 2026

For a solid yield and strong upside potential, this pharmaceutical stock is worth considering.

Via The Motley Fool

Topics Intellectual Property Stocks

The Best Stocks to Invest $500 in Right Now ↗

June 04, 2026

The market is underestimating these companies' long-term prospects.

Via The Motley Fool

Dry eye syndrome drugs Market Size, Industry Report By 2035 ↗

June 04, 2026

The most recent research report on the "Dry eye syndrome drugs Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic foreca

Via Talk Markets

Topics Economy

Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Year, According to Wall Street ↗

June 03, 2026

Wall Street analysts expect market-beating returns from healthcare and communication services stocks over the next year.

Via The Motley Fool

Topics ETFs Intellectual Property Stocks

Higher Yield or Broader Dividend Diversification? VYM vs. HDV ↗

June 02, 2026

The Vanguard High Dividend Yield ETF (VYM) and the iShares Core High Dividend ETF (HDV) both provide exposure to U.S. dividend equities, but their income profiles are built differently. For investors...

Via The Motley Fool

Topics ETFs

Johnson & Johnson Hopes to Dethrone AbbVie's Biggest Growth Driver. Here's Why Investors Shouldn't Panic ↗

June 02, 2026

AbbVie's shareholders can sleep easy.

Via The Motley Fool

The S&P 500 Is Expensive, but These 3 Dividend Stocks Still Look Like Bargains ↗

June 02, 2026

AbbVie, CVS Health, and Verizon Communications are all high-yielding stocks with attractive valuations and robust financials.

Via The Motley Fool

Topics Stocks

3 Dividend Stocks to Buy and Hold Forever ↗

June 02, 2026

These aren't the most exciting businesses, but they have a lot to offer to long-term investors.

Via The Motley Fool

U.S. Health Care Depth or Global Industry Reach? VHT vs. IXJ ↗

June 01, 2026

The Vanguard Health Care ETF (VHT) and the iShares Global Healthcare ETF (IXJ) both target health care stocks, but they are tailored to different investor needs. One emphasizes broad, low-cost U.S....

Via The Motley Fool

Topics ETFs Intellectual Property

AbbVie vs. Pfizer: Which Healthcare Stock Is a Better Buy in 2026? ↗

June 01, 2026

AbbVie and Pfizer chart distinct paths in revenue growth, risk, and valuation. Explore how their financials and strategies stack up for investors this year.

Via The Motley Fool

Topics Intellectual Property

Allergy Treatment Market Size, Growth, Forecast By 2035 ↗

June 01, 2026

The most recent research report on the "Allergy Treatment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts,

Via Talk Markets

Topics Economy

Addiction Treatment Market Size, Demand, Growth By 2035 ↗

May 29, 2026

The most recent research report on the "Addiction Treatment Market"covering the years 2026 to 2035, provides in-depth analysis, accurate economic forecasts

Via Talk Markets

Topics Economy

VYM vs. SCHD: Which U.S. Dividend ETF Is a Better Buy? ↗

May 29, 2026

When choosing dividend ETFs, diversification is a top priority.

Via The Motley Fool

Topics ETFs

2 ETFs That Have Held Up Best During Every Recent Market Pullback ↗

May 29, 2026

These two exchange-traded funds have soundly beaten the markets during recent downturns.

Via The Motley Fool

Topics ETFs Stocks

Hims & Hers Eyes Global Growth: Will $1.15B Eucalyptus Deal Fuel Its Recovery or Dilute Shareholders? ↗

May 28, 2026

Hims & Hers is acquiring Australian telehealth platform Eucalyptus as part of its international expansion plan while using $350 million in convertible senior notes.

Via MarketBeat

Topics Earnings

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.